VECTURA GMBH has a total of 54 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets medical technology, pharmaceuticals and computer technology are UROPHARMA LTD, CILAG AG INT and De Motu Cordis Pty Ltd.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | United States | 7 | |
#3 | Australia | 6 | |
#4 | Canada | 5 | |
#5 | Hungary | 3 | |
#6 | Republic of Korea | 3 | |
#7 | New Zealand | 3 | |
#8 | China | 2 | |
#9 | Hong Kong | 2 | |
#10 | Israel | 2 | |
#11 | Singapore | 2 | |
#12 | Chile | 1 | |
#13 | India | 1 | |
#14 | Japan | 1 | |
#15 | Slovenia | 1 | |
#16 | Taiwan | 1 | |
#17 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Environmental technology | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Syringes | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Healthcare informatics | |
#5 | Climate change adaptation technologies | |
#6 | Electric digital data processing | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Kolb Tobias | 35 |
#2 | Huber Martin | 34 |
#3 | Hartmann Monika | 23 |
#4 | Muellinger Bernhard | 18 |
#5 | Mullinger Bernhard | 12 |
#6 | Seeger Werner | 10 |
#7 | Voswinckel Robert | 10 |
#8 | Hoffmann Tobias | 10 |
#9 | Gessler Tobias | 10 |
#10 | Schmehl Thomas | 10 |
Publication | Filing date | Title |
---|---|---|
CN105636628A | Dosing system for an inhalation device | |
EP2914244A1 | Administration of aerosolised iloprost | |
US2015174343A1 | Mixing channel for an inhalation device and inhalation device | |
EP2724741A1 | Inhalation device for use in aerosol therapy | |
TW201249442A | Administration of iloprost as aerosol bolus | |
EP2393477A1 | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma | |
EP2067497A1 | Methods, systems and computer-readable products for optimizing aerosol particle administration to the lungs |